Data Mining and Computational Modeling of High-Throughput Screening Datasets.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Chemistry, Medicine, Computer Science

• Identifiers
  DOI 10.1007/978-1-4939-7724-6_14PMID 29671272PMCID PMC6181121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Open Source Bayesian Models. 3. Composite Models for Prediction of Binned Responses

  2016cited by this paper
• Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization

  2016cited by this paper
• The ELF Honest Data Broker: informatics enabling public-private collaboration in a precompetitive arena.

  2016cited by this paper
• Academic partnerships 2015

  2016cited by this paper
• Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data

  2016cited by this paper
• The promise and peril of chemical probes.

  2015cited by this paper
• Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

  2015cited by this paper
• Machine learning models identify molecules active against the Ebola virus in vitro

  2015cited by this paper
• Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods

  2015cited by this paper
• Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery

  2015cited by this paper
• Making Transporter Models for Drug–Drug Interaction Prediction Mobile

  2015cited by this paper
• Mining Chemical Activity Status from High-Throughput Screening Assays

  2015cited by this paper
• Open Source Bayesian Models. 2. Mining a "Big Dataset" To Create and Validate Models with ChEMBL

  2015cited by this paper
• Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.

  2014cited by this paper
• Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

  2014cited by this paper
• Parallel Worlds of Public and Commercial Bioactive Chemistry Data

  2014cited by this paper
• Looking Back to the Future: Predicting in Vivo Efficacy of Small Molecules versus Mycobacterium tuberculosis

  2014cited by this paper
• Computational Prediction and Validation of an Expert's Evaluation of Chemical Probes

  2014cited by this paper
• New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0

  2014cited by this paper
• Composition and applications of focus libraries to phenotypic assays

  2014cited by this paper
• BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types

  2014cited by this paper
• The ChEMBL database: a taster for medicinal chemists.

  2014cited by this paper
• Combining Computational Methods for Hit to Lead Optimization in Mycobacterium Tuberculosis Drug Discovery

  2013cited by this paper
• Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

  2013cited by this paper
• Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models

  2013cited by this paper
• Mining basic active structures from a large-scale database

  2013cited by this paper
• Fusing Dual-Event Data Sets for Mycobacterium tuberculosis Machine Learning Models and Their Evaluation

  2013cited by this paper
• Four disruptive strategies for removing drug discovery bottlenecks.

  2013cited by this paper
• The ChEMBL bioactivity database: an update

  2013cited by this paper
• Mining collections of compounds with Screening Assistant 2

  2012cited by this paper
• INAUGURAL ARTICLE by a Recently Elected Academy Member:Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials

  2012cited by this paper
• A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis

  2012cited by this paper
• Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.

  2012cited by this paper
• A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets

  2012cited by this paper
• Decision tree models for data mining in hit discovery

  2012cited by this paper
• Dissecting Kinase Profiling Data to Predict Activity and Understand Cross-Reactivity of Kinase Inhibitors

  2012cited by this paper
• Structural approaches to obtain kinase selectivity.

  2012cited by this paper
• Navigating the kinome.

  2011cited by this paper
• Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

  2011cited by this paper
• ChEMBL: a large-scale bioactivity database for drug discovery

  2011cited by this paper
• Comprehensive analysis of kinase inhibitor selectivity

  2011cited by this paper
• US academic drug discovery

  2011cited by this paper
• Pioneering Use of the Cloud for Development of Collaborative Drug Discovery (CDD) Database

  2011cited by this paper
• Impact of high-throughput screening in biomedical research

  2011cited by this paper
• National Institutes of Health. Drug-screening program looking for a home.

  2011cited by this paper
• Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties

  2010cited by this paper
• Leads for antitubercular compounds from kinase inhibitor library screens.

  2010cited by this paper
• Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles

  2010cited by this paper
• Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition.

  2010cited by this paper
• Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

  2010cited by this paper
• Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

  2009cited by this paper
• An overview of the PubChem BioAssay resource

  2009cited by this paper
• A quantitative high-throughput screen for modulators of IL-6 signaling: a model for interrogating biological networks using chemical libraries.

  2009cited by this paper
• A crowdsourcing evaluation of the NIH chemical probes.

  2009cited by this paper
• PubChem: a public information system for analyzing bioactivities of small molecules

  2009cited by this paper
• FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects

  2008cited by this paper
• Free resources to assist structure-based virtual ligand screening experiments.

  2007cited by this paper
• In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Comparison of Topological, Shape, and Docking Methods in Virtual Screening

  2007cited by this paper
• Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data

  2007cited by this paper
• Computational Approaches That Predict Metabolic Intermediate Complex Formation with CYP3A4 (+b5)

  2007cited by this paper
• Computational toxicology : risk assessment for pharmaceutical and environmental chemicals

  2007cited by this paper
• In silico pharmacology for drug discovery: applications to targets and beyond

  2007cited by this paper
• The ToxCast program for prioritizing toxicity testing of environmental chemicals.

  2007cited by this paper
• Learning from the Data: Mining of Large High-Throughput Screening Databases

  2006cited by this paper
• A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human.

  2006cited by this paper
• Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection.

  2005cited by this paper
• Integrating virtual screening in lead discovery.

  2004cited by this paper
• Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.

  2004cited by this paper
• Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.

  2002cited by this paper
• Prediction of 'drug-likeness'.

  2002cited by this paper
• Towards a new age of virtual ADME/TOX and multidimensional drug discovery

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.

  2001cited by this paper
• Property-based design: optimization of drug absorption and pharmacokinetics.

  2001cited by this paper
• ElogPoct: a tool for lipophilicity determination in drug discovery.

  2000cited by this paper
• Present and future in vitro approaches for drug metabolism.

  2000cited by this paper
• Computation of brain-blood partitioning of organic solutes via free energy calculations.

  1996cited by this paper

• Enhancing the sustainability of microalgae cultivation through biosensing technology

  2025cites this paper
• Production of marine-derived bioactive peptide molecules for industrial applications: A reverse engineering approach.

  2024cites this paper
• Sensing and sensitivity: Computational chemistry of graphene‐based sensors

  2021cites this paper
• Computational modelling of process–structure–property–performance relationships in metal additive manufacturing: a review

  2021cites this paper
• Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach

  2021cites this paper
• DMSO_A_320808 3437..3445

  2021cites this paper
• A Web Repository System for Data Mining in Drug Discovery

  2020cites this paper
• DMSO_A_279329 4621..4630

  2020cites this paper
• Estimation of Diabetes in a High-Risk Adult Chinese Population Using J48 Decision Tree Model

  2020cites this paper
• Selecting machine-learning scoring functions for structure-based virtual screening.

  2019cites this paper
• Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus

  2019cites this paper
• Cheminformatics techniques in antimalarial drug discovery and development from natural products 1: basic concepts

  2019cites this paper
• The Distribution of Standard Deviations Applied to High Throughput Screening

  2019cites this paper